Related Experiment Videos
Multiple sclerosis: oligodendrocytes in active lesions do not express class II major histocompatibility complex
1Department of Pathology (Neuropathology) Rose F. Kennedy Center for Research in Mental Retardation and Human Development, Albert Einstein College of Medicine, Bronx, NY 10461.
Journal of Neuroimmunology
|December 1, 1989
Summary
Oligodendrocytes do not express major histocompatibility complex (MHC) class II molecules in active multiple sclerosis (MS) lesions. This finding suggests oligodendrocytes are unlikely to modulate the MS immune response within lesions.
Area of Science:
- Neuroimmunology
- Cellular Biology
Background:
- The role of oligodendrocytes in multiple sclerosis (MS) pathogenesis is debated.
- Previous studies suggested oligodendrocytes express major histocompatibility complex (MHC) molecules in MS lesions, but evidence was controversial and primarily in vitro.
- Major histocompatibility complex (MHC) class II (Ia) expression is critical for antigen presentation and immune modulation.
Observation:
- This study utilized immunocytochemistry on central nervous system biopsy sections from an acute MS case.
- The researchers examined the expression of MHC class II (Ia) molecules on cells within active demyelinating lesions.
- They also assessed the expression of myelin-associated glycoprotein (MAG), a marker for immature oligodendrocytes.
Findings:
- MHC class II (Ia) molecules were detected on microglial cells and astrocytes within MS lesions.
- Crucially, MHC class II (Ia) expression was never found on adjacent, surviving oligodendrocytes.
- Oligodendrocytes in these lesions unexpectedly stained positive for myelin-associated glycoprotein (MAG).
Implications:
- The absence of MHC class II (Ia) expression on oligodendrocytes challenges their role as direct immunomodulators in MS lesion development.
- These findings suggest that oligodendrocytes may not directly present antigens or initiate immune responses within the MS lesion.
- The presence of MAG indicates potential immaturity or a specific differentiation state of oligodendrocytes in active lesions, warranting further investigation.